雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Novel Therapy in Guillain-Barré Syndrome Motoi Kuwahara 1 , Susumu Kusunoki 1 1Department of Neurology, Kindai University Faculty of Medicine Keyword: ギラン・バレー症候群 , 新規治療法 , エクリズマブ , J-GOS , Guillain-Barré syndrome , novel therapy , Eculizumab , Japan GBS outcome study (J-GOS) pp.1423-1429
Published Date 2016/12/1
DOI https://doi.org/10.11477/mf.1416200612
  • Abstract
  • Look Inside
  • Reference

Abstract

The efficacy of plasma exchange (PE) and intravenous immunoglobulin (IVIg) therapies for Guillain-Barré syndrome have been established by numerous randomized controlled trials. However, 10-20 % of GBS patients cannot walk without aid after one year from onset of the disease. Thus, new treatment is required for these intractable cases. The Japan GBS outcome study (J-GOS) has been conducted to identify clinical or biological markers that predict the prognosis of Japanese GBS patients at an early stage. In the future, we expect to provide intractable patients so predicted with novel therapy, including molecular target drugs.


Copyright © 2016, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有